Novo Nordisk is Falling. A Rival Weight-Loss Drug Is on the Way.
Novo Nordisk stock was dropping on Wednesday after Roche said it had licensed a promising obesity drug in a deal that could ...
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4%
The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on the news. Meanwhile, Novo Nordisk's stock was hit, sliding 4%, and Eli Lilly's stock was down ...
Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in.
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the product, assuming it gains regulatory approval. Viking ...